Omega Therapeutics, Inc. (OMGAQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0550
+0.0070 (14.58%)
Apr 17, 2025, 4:00 PM EDT
Omega Therapeutics Revenue
Omega Therapeutics had revenue of $2.61M in the quarter ending September 30, 2024, with 214.32% growth. This brings the company's revenue in the last twelve months to $8.10M, up 185.04% year-over-year. In the year 2023, Omega Therapeutics had annual revenue of $3.09M with 49.25% growth.
Revenue (ttm)
8.10M
Revenue Growth
+185.04%
P/S Ratio
0.38
Revenue / Employee
86.12K
Employees
94
Market Cap
3.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.09M | 1.02M | 49.25% |
| Dec 31, 2022 | 2.07M | 1.93M | 1,339.58% |
| Dec 31, 2021 | 144.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |